These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12010810)

  • 41. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.
    Liang Y; Xu RZ; Zhang L; Zhao XY
    Acta Pharmacol Sin; 2009 Dec; 30(12):1659-65. PubMed ID: 19960011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.
    Watanabe M; Dewan MZ; Okamura T; Sasaki M; Itoh K; Higashihara M; Mizoguchi H; Honda M; Sata T; Watanabe T; Yamamoto N; Umezawa K; Horie R
    Int J Cancer; 2005 Mar; 114(1):32-8. PubMed ID: 15523684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of NF-kappaB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance.
    Anto RJ; Venkatraman M; Karunagaran D
    J Biol Chem; 2003 Jul; 278(28):25490-8. PubMed ID: 12714587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
    Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
    Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.
    Yinjun L; Jie J; Yungui W
    Leuk Res; 2005 Jan; 29(1):99-105. PubMed ID: 15541481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways.
    Jones BE; Lo CR; Liu H; Srinivasan A; Streetz K; Valentino KL; Czaja MJ
    J Biol Chem; 2000 Jan; 275(1):705-12. PubMed ID: 10617670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis.
    Takada Y; Khuri FR; Aggarwal BB
    J Biol Chem; 2004 Jun; 279(25):26287-99. PubMed ID: 15090542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.
    Qi H; Ohh M
    Cancer Res; 2003 Nov; 63(21):7076-80. PubMed ID: 14612498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB.
    Pozo-Guisado E; Merino JM; Mulero-Navarro S; Lorenzo-Benayas MJ; Centeno F; Alvarez-Barrientos A; Fernandez-Salguero PM
    Int J Cancer; 2005 May; 115(1):74-84. PubMed ID: 15688415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.
    Lwin T; Hazlehurst LA; Li Z; Dessureault S; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Leukemia; 2007 Jul; 21(7):1521-31. PubMed ID: 17476277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
    Ahn KS; Sethi G; Aggarwal BB
    Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3.
    Kolenko V; Bloom T; Rayman P; Bukowski R; Hsi E; Finke J
    J Immunol; 1999 Jul; 163(2):590-8. PubMed ID: 10395645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
    Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
    Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells.
    Dai Y; Pei XY; Rahmani M; Conrad DH; Dent P; Grant S
    Blood; 2004 Apr; 103(7):2761-70. PubMed ID: 14645003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.